Related Experiment Video
Updated: May 6, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Pressure ulcer treatment in pediatric patients
Anna-Barbara Schlüer1, Jos M G A Schols, Ruud J G Halfens
1Anna-Barbara Schlüer, MScN, is a Nursing Scientist in the Department of Nursing Development and Science, and the Children's Research Center, at the University Children's Hospital Zurich, Zurich, Switzerland. Jos M. G. A. Schols, MD, PhD, is a Professor in the Departments of Family Medicine and Health Services Research; and Ruud J. G. Halfens, PhD, is an Associate Professor of Nursing Science in the Department of Health Services Research, both at CAPHRI-Maastricht University, Maastricht, the Netherlands.
Objective:
To assess pressure ulcer (PrU) treatment in Swiss hospitalized pediatric patients and to determine whether there are differences in PrU treatment, according to demographic characteristics of the patients.
Design:
A descriptive multicenter point prevalence study was conducted in June 2009 in all German-speaking pediatric hospitals in Switzerland.
Setting:
All hospitalized patients from birth up to 17 years or younger in 14 Swiss pediatric hospitals, including all pediatric departments, were assessed.
Patients:
A total of 412 patients participated in this study.
Main Outcome Measures:
The instrument and method of the Dutch National Prevalence Measurement of Care Problems were used.
Main Results:
Thirty-five percent of the patients had a PrU. Almost all of these PrUs (94.1%) were of category 1. The most severe PrUs occurred in patients older than 8 years. Age of the patient and department were the only characteristics that significantly influenced the occurrence of PrU categories 2 to 4. Pressure ulcer categories 2 to 4 were mostly covered with hydrocolloid or polyurethane foam dressings. No pediatric-specific guideline regarding PrU treatment is used in the involved hospitals.
Conclusion:
Most patients had category 1 PrUs, so appropriate prevention to decrease any further trauma in these patients was necessary. Severe PrUs (categories 2-4) are mostly limited to older pediatric (aged >8 years) patients with chronic conditions or after surgery intervention. A PrU treatment guideline adapted for pediatric needs is recommended.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

